Condition
Primary Immune Regulatory Disorder clinical trials and research
As of November 12, 2026, Find a Trial lists 4 Primary Immune Regulatory Disorder clinical trials that are recruiting, at sites in 2 countries (most in United States (3), Italy (1)). 1 was first registered in the last 30 days. By phase: Phase 2 (2), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 4Clinical trials
- 1New in 30 days
- 2Countries
Newest Primary Immune Regulatory Disorder clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| Understanding congenital bone marrow failure and related disorders through a national network | — | Avellino and 3 other locations | Recruiting | Oct 16, 2026 |
| Reduced-intensity hematopoietic stem cell transplant for CVID and other primary immune regulatory disorders | Phase 2 | Pittsburgh, Pennsylvania | Recruiting | Dec 16, 2025 |
| Using CD45RA Depleted Stem Cells to Prevent Infections After Transplant | Phase 1/2 | Philadelphia, Pennsylvania | Recruiting | Feb 21, 2025 |
| Treatment of inflammation before stem cell transplant for immune disorders | Phase 2 | San Francisco, California and 12 other locations | Recruiting | Mar 28, 2023 |
All recruiting trials (4)
-
Understanding congenital bone marrow failure and related disorders through a national network
This project tests whether people with rare inherited bone marrow failure syndromes or related conditions really have the underlying genetic causes, by collecting data and samples across multiple centers.
-
Reduced-intensity hematopoietic stem cell transplant for CVID and other primary immune regulatory disorders
This will try a reduced-intensity hematopoietic stem cell transplant with low-dose total body irradiation to correct or improve severe CVID and related primary immune regulatory disorders in people aged 5 to 40.
-
Using CD45RA Depleted Stem Cells to Prevent Infections After Transplant
This study is testing whether using special stem cells can help patients with high-risk leukemia recover their immune system faster and prevent infections after a stem cell transplant.
-
Treatment of inflammation before stem cell transplant for immune disorders
This study is testing if a new treatment can help reduce inflammation in people with immune disorders before they get a stem cell transplant to improve the chances of a successful procedure.
Related topics
Quick answers
How many Primary Immune Regulatory Disorder clinical trials are recruiting right now?
4, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in United States (3 trials), Italy (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 2: 2, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.